TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer
TROP2 marks poor-prognosis colorectal cancer cells with fetal-like, therapy-resistant states, and therapeutic targeting of TROP2 with antibody–drug conjugates in combination with chemotherapy enhances treatment efficacy by modulating tumour cell plasticity an…
Read Full Story 🔹 Subscribe
#News ⚡️ #AI ⚡️ #Tech
Post #2452
426

- 👍 1